A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome

High-dose IV iron failed to demonstrate the robust changes reported in three prior open-label studies. Differences in iron formulation, dosing regiment, and peripheral iron status may explain some of the discrepancies between this and previous IV iron treatment studies.